Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H10N2O |
Molecular Weight | 174.1992 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NN(C(=O)C1)C2=CC=CC=C2
InChI
InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N
InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
Molecular Formula | C10H10N2O |
Molecular Weight | 174.1992 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:32:23 UTC 2023
by
admin
on
Sat Dec 16 19:32:23 UTC 2023
|
Record UNII |
S798V6YJRP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
847021
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
WHO-ATC |
N07XX14
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
478215
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
754420
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/15/1510
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
465514
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RADICUT
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | APPROVED JUNE 2015 | ||
|
DB12243
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
1921877
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
31530
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
2629
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
12
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
100000088126
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
89-25-8
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
C005435
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
S798V6YJRP
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL290916
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
4021
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
26139
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
942-32-5
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
ALTERNATIVE | |||
|
4102
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
EDARAVONE
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
201-891-0
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
19735-89-8
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
ALTERNATIVE | |||
|
7362
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
4156
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
SUB06453MIG
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
m8072
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
1040016
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
213-390-4
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
ALTERNATIVE | |||
|
C74323
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
DTXSID9021130
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
S798V6YJRP
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY | |||
|
DE-18
Created by
admin on Sat Dec 16 19:32:27 UTC 2023 , Edited by admin on Sat Dec 16 19:32:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE |
WEAK
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
IN-VITRO
Km
|
||
|
TRANSPORTER -> INHIBITOR |
Edaravone inhib it e d CYP2C9, BCRP, OAT3, and induced CYP1A2 in vitro.
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INDUCER |
Edaravone inhib it e d CYP2C9, BCRP, OAT3, and induced CYP1A2 in vitro.
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
IN-VITRO
Km
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
IN-VITRO
Km
|
||
|
METABOLIC ENZYME -> INHIBITOR |
Edaravone inhib it e d CYP2C9, BCRP, OAT3, and induced CYP1A2 in vitro.
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR |
Edaravone inhib it e d CYP2C9, BCRP, OAT3, and induced CYP1A2 in vitro.
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
IN-VITRO
Km
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT | |||
|
PARENT -> METABOLITE | |||
|
METABOLITE INACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |